CLD004) for 10 days and stained with (A) Mouse Anti-Human KIR2DL4/CD158d Monoclonal Antibody (Catalog # MAB2238) or (B) Mouse IgG2A isotype control Antibody (
MAB003) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse Anti-Human NCAM-1/CD56 APC-conjugated Monoclonal Antibody (
FAB2408A). Staining was performed using our Staining Membrane-associated Proteins protocol. " class="big_lightbox">

CLD004) for 10 days and stained with (A) Mouse Anti-Human KIR2DL4/CD158d Monoclonal Antibody (Catalog # MAB2238) or (B) Mouse IgG2A isotype control Antibody (
MAB003) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse Anti-Human NCAM-1/CD56 APC-conjugated Monoclonal Antibody (
FAB2408A). Staining was performed using our Staining Membrane-associated Proteins protocol. " alt="Human peripheral blood mononuclear cell (PBMC) NK cells were expanded with Cloudz Human NK Cell Expansion Kit (
CLD004) for 10 days and stained with (A) Mouse Anti-Human KIR2DL4/CD158d Monoclonal Antibody (Catalog # MAB2238) or (B) Mouse IgG2A isotype control Antibody (
MAB003) followed by Anti-Mouse IgG PE-conjugated Secondary Antibody (
F0102B) and Mouse Anti-Human NCAM-1/CD56 APC-conjugated Monoclonal Antibody (
FAB2408A). Staining was performed using our Staining Membrane-associated Proteins protocol. " class="big_thumb" />